C12Y 110/02002
Ubiquinol-cytochrome-c reductase , i.e. electron-transport-complex-iii
Official title: Ubiquinol-cytochrome-c reductase (1.10.2.2), i.e. electron-transport-complex-III
C12Y110/02002 (Ubiquinol-cytochrome-c reductase , i.e. electron-transport-complex-iii) appears on 8 US grants and 16 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 16
- Assignees
- 7
- Inventors
- 14
- Latest grant
- 29 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 3 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Compositions and methods for improving mitochondrial function29 Apr 2025US 12,285,446 B2The General Hospital Corporation
- Compositions and methods for improving mitochondrial function29 Aug 2023US 11,738,056 B2The General Hospital Corporation
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof12 Oct 2021US 11,141,456 B2Stealth BioTherapeutics Inc.
- Compositions and methods for improving mitochondrial function13 Apr 2021US 10,973,860 B2The General Hospital Corporation
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof3 Mar 2020US 10,576,124 B2Stealth BioTherapeutics Inc.
- Compositions and methods for improving mitochondrial function11 Sep 2025US 2025/0281550 A1The General Hospital Corporation
- Compositions and methods for improving mitochondrial function14 Mar 2024US 2024/0082315 A1The General Hospital Corporation
- Cell-Free Compositions for ATP Regeneration and Uses Thereof12 May 2022US 2022/0145282 A1Biocheminsights, Inc.
- Compositions and methods for improving mitochondrial function15 Jul 2021US 2021/0213074 A1The General Hospital Corporation
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof15 Oct 2020US 2020/0323947 A1Stealth BioTherapeutics Inc.
Most cited
By later US patents
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 10,576,124 B2Stealth BioTherapeutics Inc. · 2020
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 11,141,456 B2Stealth BioTherapeutics Inc. · 2021
- Compositions and methods for improving mitochondrial function1US 11,738,056 B2The General Hospital Corporation · 2023
- PTD-UQCRB fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same1US 8,729,021 B2Industry-Academic Cooperation Foundation, Yonsei University · 2014